Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
36
IRME Quote, Financials, Valuation and Earnings
Last price:
$0.05
Seasonality move
:
6.32%
Day range:
$0.05 - $0.05
52-week range:
$0.01 - $0.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
16,201.82x
Volume:
--
Avg. volume:
7.3K
1-year change:
-94.35%
Market cap:
$3.6M
Revenue:
--
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, IR-Med, Inc. has -- downside to fair value with a price target of -- per share.
IRME vs. S&P 500
-
Over the past 5 trading days, IR-Med, Inc. has overperformed the S&P 500 by 1.92% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
IR-Med, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IR-Med, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter IR-Med, Inc. reported revenues of --.
Earnings Growth
-
IR-Med, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter IR-Med, Inc. reported earnings per share of -$0.01.
Enterprise value:
3.8M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.55x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$15K
Return On Assets:
-596.45%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$17K | -$17K | -$15K | -$4K | -$4K | |
| Operating Income | -$5.4M | -$3.5M | -$1.5M | -$358K | -$286K | |
| EBITDA | -$5.4M | -$3.5M | -$1.4M | -$354K | -$282K | |
| Diluted EPS | -$0.08 | -$0.05 | -$0.03 | -$0.01 | -$0.01 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.3M | $4.2M | $2.4M | $789K | $90K | |
| Total Assets | $4.3M | $4.5M | $2.6M | $887K | $175K | |
| Current Liabilities | $299K | $370K | $601K | $367K | $774K | |
| Total Liabilities | $466K | $608K | $614K | $524K | $800K | |
| Total Equity | $3.9M | $3.9M | $2M | $363K | -$625K | |
| Total Debt | $167K | $238K | $169K | $157K | $26K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.1M | -$2.3M | -$837K | -$372K | -$71K | |
| Cash From Investing | -$14K | -$2K | -- | -- | -- | |
| Cash From Financing | $1.4M | $715K | $154K | $715K | $88K | |
| Free Cash Flow | -$3.1M | -$2.3M | -$837K | -$372K | -$71K | |
IRME
Sector
Market Cap
$3.6M
$28.4M
Price % of 52-Week High
5.65%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-2.46%
-1.32%
1-Year Price Total Return
-94.35%
-22.19%
Beta (5-Year)
2.696
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.05
200-day SMA
Sell
Level
$0.13
Bollinger Bands (100)
Buy
Level
0.02 - 0.04
Chaikin Money Flow
Sell
Level
-3M
20-day SMA
Buy
Level
$0.04
Relative Strength Index (RSI14)
Buy
Level
60.25
ADX Line
Buy
Level
13.21
Williams %R
Sell
Level
-19.375
50-day SMA
Buy
Level
$0.04
MACD (12, 26)
Buy
Level
0.00
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Sell
Level
-3.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-83.9557)
Sell
CA Score
(Annual)
Level (-16.5009)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (30.5858)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (0)
Revenue Forecast
Earnings per Share Forecast
Company Profile
IR-Med, Inc. is engaged in the designing and developing devices utilizing spectrographic usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies. The company was founded by Ronnie Klein and Yaniv Cohen in April 2007 and is headquartered in Rosh Pinna, Israel.
Stock Forecast FAQ
In the current month, IRME has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IRME average analyst price target in the past 3 months is --.
-
Where Will IR-Med, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that IR-Med, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About IR-Med, Inc.?
Analysts are divided on their view about IR-Med, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IR-Med, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is IR-Med, Inc.'s Price Target?
The price target for IR-Med, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IRME A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IR-Med, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IRME?
You can purchase shares of IR-Med, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IR-Med, Inc. shares.
-
What Is The IR-Med, Inc. Share Price Today?
IR-Med, Inc. was last trading at $0.05 per share. This represents the most recent stock quote for IR-Med, Inc.. Yesterday, IR-Med, Inc. closed at $0.05 per share.
-
How To Buy IR-Med, Inc. Stock Online?
In order to purchase IR-Med, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get IRME Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IRME
Sector
P/E ratio
--
23.66x
PEG ratio
--
-0.01x
P/B ratio
16,201.82x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
IRME
Sector
Revenue growth
--
4.85%
Earnings growth
--
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
--
-$0.20
Profitability
IRME
Sector
Profitability FY 2024
-$21K
$3.6M
Return on invested capital
--
-30.98%
Return on assets
-596.45%
-27.62%
Return on equity
--
-36.69%
Earnings Date
Last Earnings Date
Dec
5
Next Earnings Date
Dec
5
Estimated Next Earnings Date
Mar
6
Balance Sheet
IRME
Sector
Total cash
$63K
$27.2M
Short term investments
--
$25.7M
Total assets
$251K
$79.9M
Long term debt
$250K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
